Comprised of Takeda's global oncology commercial operations, Takeda Oncology operates in close alignment with Takeda's dedicated global oncology R&D function, the Oncology Therapeutic Area Unit (OTAU), to drive forward the company's products while maintaining a focus on expanding our oncology pipeline.
The organizational structure and governance model for Takeda Oncology is designed to drive customer proximity, nimbleness, agility and accountability. Consistent with these principles, Takeda Oncology operates with a relatively flat organization that allows close proximity to patients and customers, so that we can deeply understand and address their unique and changing needs.
Takeda Oncology is comprised of the following functions and led by the following individuals:
Liz Lewis
Head, Global Oncology Patient Value, Policy and Access, Oncology Business Unit